mchakravarti7
I attempted to solve these problems in one go by building Flock, where you can create wishlists from any items on the internet (i.e. you don't have to create a separate wishlist for Amazon, Best Buy items, etc.) for any (or no) occasion. Once you create a wishlist, you can then share it with family and friends, and they can contribute towards your wishlist GoFundMe style!
Here's my wishlist: https://myflock.app/@mohnish
This is the first time I've actually built and shipped something from scratch by myself. I'd love feedback on the design/technicality, and even take feature requests if you have any!
I built this using Node and React, and it is hosted on Firebase for now.
There are lots of benefits to registering in DE compared to some other states in the US, but I'm unsure of any benefits compared to incorporating in the region you are based out of.
I'd suggest talking to an attorney and learning more about this before incorporating. Jared Stark (http://starkbusinesslaw.com/) helped us incorporate and is really helpful
International student founders – how did you solve the issue with visas?
Will need to incorporate soon, so I'm looking for advice on how to go on about eventual issues that will arise as an international student in the US. I'm currently on an F1 visa.As far as I understand, there's two options I can use immediately (until I find enough resources to move off the F1 visa): 1) CPT, 2) pre-OPT.Can I even use CPT to work on my startup? Would incorporating in my home...
Post incorporation things to take care of while using Stripe Atlas
Currently in the process of evaluating services to use in order to incorporate a company, and I'm a bit confused about what post-incorporation documentation does Stripe Atlas actually provide help with. They say that they provide templates for all the documents, but what kind of documents are actually left to be submitted? the 83b form is one that comes to mind.I'd appreciate it if anybody who...
With Trump picking Scott Gottlieb to be the next FDA commissioner, the FDA approval process is expected to get more lenient. Would you say that YC (or investors in general) would be open to take more risks with high tech startups that do not have a clinically validated product as of now?
One more question - Given that the FDA process takes a lot of time, quite a few biotech companies often get acquired or merged with bigger companies that can afford to do so, without ever having actually gotten their product out on the market. Would you say that you look at the company's potential return in that sense when you evaluate startups? I'm not entirely sure if this question makes sense, so let me know if you want me to clarify!